3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
10
Lung Neoplasms
6
Adenocarcinoma of Lung
4
Adenocarcinoma, Bronchiolo-Alveolar
2
Solitary Pulmonary Nodule
1
Respiratory Aspiration
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
NSCLC
1
Multiple Pulmonary Nodules
1
Liver Neoplasms
1
Gastrointestinal Neoplasms
1
Disease
1
Interventions
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Cyclophosphamide
6
Blood Specimen Collection
6
Prednisone
5
Positron Emission Tomography Computed Tomography
4
Mammography
4
Lenalidomide
4
Colonoscopy
4
pembrolizumab
3
Tomography, X-Ray Computed
3
Surveys and Questionnaires
3
Melphalan
3
Exercise
3
Biopsy
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
weifuchun
2
obinutuzumab
2
fluciclovine F-18
2
daratumumab
2
carfilzomib
2
Preoperative Exercise
2
Positron-Emission Tomography
2
Methods
2
Magnetic Resonance Imaging
2
Injections
2
Gemcitabine
2
Educational Status
2
Doxorubicin
2
Cytarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Disease
×
Anterior Temporal Lobectomy
×
Clear all
NCT02951897
2016-11-02
CTCs detection
Third Military Medical University
Phase NA
Unknown
120 enrolled